Overactive Bladder

Oncology·MeSH: Agnosia

27 drugs in development·5 companies·15 clinical trials

Drug Pipeline by Phase

Approved(1)

Drug	Company
toviaz	PFIZER INC (PFE)

Phase 2(2)

Drug	Company
Platelet-Rich Plasma	Revance Therapeutics, Inc. (RVNC)
uro-902	Urovant Sciences Ltd. (UROV)

Preclinical(2)

Drug	Company
abp-450	AEON Biopharma, Inc. (AEON)
jnp-0101	JUNIPER PHARMACEUTICALS INC (JNP)

Unknown(7)

Drug	Company
Atogepant	Revance Therapeutics, Inc. (RVNC)
Eptinezumab	Revance Therapeutics, Inc. (RVNC)
Erenumab	Revance Therapeutics, Inc. (RVNC)
Fremanezumab	Revance Therapeutics, Inc. (RVNC)
Galcanezumab	Revance Therapeutics, Inc. (RVNC)
Rimegepant	Revance Therapeutics, Inc. (RVNC)
Ubrogepant	Revance Therapeutics, Inc. (RVNC)

N/A(1)

Drug	Company
Urodynamic evaluation before and after mirabegron treatment.	Revance Therapeutics, Inc. (RVNC)

Phase 4(14)

Drug	Company
Bicarbonate protocol	Revance Therapeutics, Inc. (RVNC)
Botox 100 Unit Injection	Revance Therapeutics, Inc. (RVNC)
Botox 50 Unit Injection	Revance Therapeutics, Inc. (RVNC)
Botulinum Toxin A	Revance Therapeutics, Inc. (RVNC)
Ciprofloxacin	Revance Therapeutics, Inc. (RVNC)
Intradetrusor Botox Injections	Revance Therapeutics, Inc. (RVNC)
Intravesical Botulinum Toxin Injection	Revance Therapeutics, Inc. (RVNC)
Methenamine Hippurate	Revance Therapeutics, Inc. (RVNC)
onabotulinum toxin type a	Revance Therapeutics, Inc. (RVNC)
OnabotulinumtoxinA 100 UNT [Botox]	Revance Therapeutics, Inc. (RVNC)
Pro-Nox Nitrous Oxide/Oxygen Delivery System	Revance Therapeutics, Inc. (RVNC)
Standard Care for Bladder Botox Injection	Revance Therapeutics, Inc. (RVNC)
Standard protocol	Revance Therapeutics, Inc. (RVNC)
Typically prescribed oral antibiotic prophylaxis	Revance Therapeutics, Inc. (RVNC)

BioSniper tracks 27 drugs in development for Overactive Bladder across 5 companies.

There are 15 clinical trials targeting Overactive Bladder tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.